Mark Levin
Sharon Schultz
Schultz Public Relations
(302) 539-3747
schultzpr@mchsi.com
RICHLAND, WASHINGTON – January 7, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at...
HOUSTON, TEXAS - January 05, 2021 – C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius® positive-signal MRI (Magnetic Resonance...
With over ten years of data on Cesium Blu, researchers continue to study its value in powering modern brachytherapy. ASTRO 2020 showcased multiple new e-posters and papers that can now be easily accessed online. A Matched Pair Analysis Of Clinical Outcomes...